BTG PLC ORD 10P

BGC 
(LSE, Stocks) 
 
p 387.50
Updated 29/05/2012
Change % 0.00% Stock price unchanged
Change 0.00 Stock price unchanged
Volume 0
High P 387.50
Low P 387.50
Open P N/A
ISIN GB0001001592
Prev close P 387.50
# of shares -
Market cap -
Intraday

Market closed
BTG PLC ORD 10P
Market is closed, opens at 08:00
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  387.50 0.0% Stock price unchanged 0.0% Stock price unchanged 0.0% Stock price unchanged 0.0% Stock price unchanged 0.0% Stock price unchanged
Powered by TradingView

Company profile

BTG is a biotechnology company that develops products in specialty areas of medicine. The company's three operating segments are interventional medicine, specialty pharmaceuticals, and licensing. Its interventional medicine focuses on oncology, vascular treatments, and pulmonology. BTG's revenue is roughly split between these three segments, while its oncology operations lead the interventional segment. The company has been known to utilize acquisitions for investing in leading therapies and capabilities.

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
21 April 2018 17:53:11
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: ReleaseBuild_20180417.1 - EUROWEB6 - 2018-04-21 18:53:11 - 2018-04-21 17:53:11 - 1000 - Website: OKAY